ES
Estrella Immunopharma, Inc.
ESLAW · NASDAQ
$0.06 -4.00% (-$0.00)
1M -10.18%
Market Cap $2.12M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 131.75%
ROA 548.74%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.20x
Debt/Equity N/A
Int. coverage N/A
Stability
43 /100
Moderate Beta -0.09x
EPS volatility 36.25%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ESLAW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheng Liu
Employees
3
Headquarters
EmeryVille
Nadcházející události
02 PRO
Earnings
Upcoming earnings report